98 related articles for article (PubMed ID: 30534678)
1. A convenient and reproducible method for the synthesis of astatinated 4-[
Watanabe S; Azim MA; Nishinaka I; Sasaki I; Ohshima Y; Yamada K; Ishioka NS
Org Biomol Chem; 2018 Dec; 17(1):165-171. PubMed ID: 30534678
[TBL] [Abstract][Full Text] [Related]
2. 1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation.
Vaidyanathan G; Zalutsky MR
Bioconjug Chem; 1992; 3(6):499-503. PubMed ID: 1463779
[TBL] [Abstract][Full Text] [Related]
3. No-carrier-added (4-fluoro-3-[131I]iodobenzyl)guanidine and (3-[211At]astato-4-fluorobenzyl)guanidine.
Vaidyanathan G; Affleck DJ; Zalutsky MR
Bioconjug Chem; 1996; 7(1):102-7. PubMed ID: 8741997
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and analysis of 2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine and their uptake in human glioma cell cultures in-vitro.
Meyer GJ; Walte A; Sriyapureddy SR; Grote M; Krull D; Korkmaz Z; Knapp WH
Appl Radiat Isot; 2010 Jun; 68(6):1060-5. PubMed ID: 20137958
[TBL] [Abstract][Full Text] [Related]
5. The development of a [211AT]-astatinated endoradiotherapeutic drug: part IV--late radiation effects.
Brown I; Mitchell JS
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1177-83. PubMed ID: 9539575
[TBL] [Abstract][Full Text] [Related]
6. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
7. The development of a [211At]-astatinated endoradiotherapeutic drug: Part II. Therapeutic results for transplanted adenocarcinoma of the rectum in mice and associated studies.
Brown I; Mitchell JS
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):115-24. PubMed ID: 8175418
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of [
Shirakami Y; Watabe T; Obata H; Kaneda K; Ooe K; Liu Y; Teramoto T; Toyoshima A; Shinohara A; Shimosegawa E; Hatazawa J; Fukase K
Sci Rep; 2021 Jun; 11(1):12982. PubMed ID: 34155314
[TBL] [Abstract][Full Text] [Related]
9. N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211At.
Vaidyanathan G; Affleck DJ; Bigner DD; Zalutsky MR
Nucl Med Biol; 2003 May; 30(4):351-9. PubMed ID: 12767391
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of 6-[211At]astato-2-methyl-1,4-naphthoquinol bis(diphosphate salt) and 211At- in mice with a transplanted rectal adenocarcinoma.
Brown I; Carpenter RN; Mitchell JS
Int J Appl Radiat Isot; 1984 Sep; 35(9):843-7. PubMed ID: 6480147
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the Therapeutic Effect of 2-
Hanaoka H; Ohshima Y; Suzuki H; Sasaki I; Watabe T; Ooe K; Watanabe S; Ishioka NS
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771676
[TBL] [Abstract][Full Text] [Related]
12. Development of a neopentyl 211At-labeled activated ester providing in vivo stable 211At-labeled antibodies for targeted alpha therapy.
Tada M; Kaizuka Y; Kannaka K; Suzuki H; Joho T; Takahashi K; Uehara T; Tanaka H
ChemMedChem; 2024 Jun; ():e202400369. PubMed ID: 38847493
[TBL] [Abstract][Full Text] [Related]
13. Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
Kersemans V; Kersemans K; Cornelissen B; Staelens L; de Spiegeleer B; Mertens J; Slegers G
Cancer Biother Radiopharm; 2006 Jun; 21(3):235-42. PubMed ID: 16918300
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vivo evaluation of linkers for 211At labeling of humanized anti-Tac.
Yordanov AT; Garmestani K; Zhang M; Zhang Z; Yao Z; Phillips KE; Herring B; Horak E; Beitzel MP; Schwarz UP; Gansow OA; Plascjak PS; Eckelman WC; Waldmann TA; Brechbiel MW
Nucl Med Biol; 2001 Oct; 28(7):845-56. PubMed ID: 11578907
[TBL] [Abstract][Full Text] [Related]
15. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
[TBL] [Abstract][Full Text] [Related]
16. Three-step, "one-pot" radiosynthesis of 6-fluoro-3,4-dihydroxy-L-phenylalanine by isotopic exchange.
Wagner FM; Ermert J; Coenen HH
J Nucl Med; 2009 Oct; 50(10):1724-9. PubMed ID: 19759110
[TBL] [Abstract][Full Text] [Related]
17. Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate.
Lindegren S; Frost S; Bäck T; Haglund E; Elgqvist J; Jensen H
J Nucl Med; 2008 Sep; 49(9):1537-45. PubMed ID: 18703591
[TBL] [Abstract][Full Text] [Related]
18. Preparation and preliminary evaluation of 4-[211At]astato-N-piperidinoethyl benzamide.
Garg PK; John CS; Zalutsky MR
Nucl Med Biol; 1995 May; 22(4):467-73. PubMed ID: 7550023
[TBL] [Abstract][Full Text] [Related]
19. Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Israel I; Brandau W; Farmakis G; Samnick S
Appl Radiat Isot; 2008 Apr; 66(4):513-22. PubMed ID: 18024046
[TBL] [Abstract][Full Text] [Related]
20. Survival and DNA damage in Chinese hamster V79 cells exposed to alpha particles emitted by DNA-incorporated astatine-211.
Walicka MA; Vaidyanathan G; Zalutsky MR; Adelstein SJ; Kassis AI
Radiat Res; 1998 Sep; 150(3):263-8. PubMed ID: 9728654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
